Literature DB >> 9631846

Postdialysis fatigue: lack of effect of a biocompatible membrane.

A H Sklar1, D H Beezhold, N Newman, T Hendrickson, A W Dreisbach.   

Abstract

Tumor necrosis factor-alpha (TNF-alpha) has been shown to have somnogenic properties. Plasma levels of this cytokine have been found to increase significantly during dialysis with a bioincompatible (cuprophane) membrane in patients with postdialysis fatigue (PDF). We conducted a crossover study with random assignment to ascertain whether a biocompatible membrane might attenuate the increase of TNF-alpha and severity of PDF. Sixteen patients on maintenance hemodialysis underwent dialysis with either cuprophane (n = 8) or polymethylmethacrylate (PMMA; n = 8) membranes for 1 week and then switched to the opposite membrane during the second week. Predialysis and postdialysis measurements of plasma TNF-alpha levels were performed during the first and last dialysis treatments of each week. A fatigue score was determined from the sum of duration of fatigue and sleep within 6 hours of the completion of dialysis. TNF-alpha levels increased by an average of 18.3% during dialysis with cuprophane membranes but only 2.4% with PMMA membranes (P = 0.04). Despite this, fatigue scores remained unaltered (approximately 4 of 6). Hence, the biocompatible membrane, PMMA, failed to alleviate PDF. This suggests that dialytic stimulation of TNF-alpha plays no substantial role in the pathogenesis of PDF.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9631846     DOI: 10.1053/ajkd.1998.v31.pm9631846

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  5 in total

1.  1-year course of fatigue in patients on chronic hemodialysis.

Authors:  Maurizio Bossola; Enrico Di Stasio; Manuela Antocicco; Gilda Pepe; Emanuele Marzetti; Carlo Vulpio
Journal:  Int Urol Nephrol       Date:  2017-01-04       Impact factor: 2.370

Review 2.  High-flux versus low-flux membranes for end-stage kidney disease.

Authors:  Suetonia C Palmer; Kannaiyan S Rabindranath; Jonathan C Craig; Paul J Roderick; Francesco Locatelli; Giovanni F M Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

Review 3.  Involvement of cytokines in slow wave sleep.

Authors:  James M Krueger; James M Clinton; Bradley D Winters; Mark R Zielinski; Ping Taishi; Kathryn A Jewett; Christopher J Davis
Journal:  Prog Brain Res       Date:  2011       Impact factor: 2.453

Review 4.  Cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.

Authors:  A M Macleod; M Campbell; J D Cody; C Daly; C Donaldson; A Grant; I Khan; K S Rabindranath; L Vale; S Wallace
Journal:  Cochrane Database Syst Rev       Date:  2005-07-20

5.  Interventions for improving sleep quality in people with chronic kidney disease.

Authors:  Patrizia Natale; Marinella Ruospo; Valeria M Saglimbene; Suetonia C Palmer; Giovanni Fm Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2019-05-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.